Vertex Pharmaceuticals Incorporated (ETR:VX1)
388.10
+0.85 (0.22%)
At close: Dec 22, 2025
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
€1,637,995
Profits / Employee
€513,490
Market Cap
99.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,100 | 700 | 12.96% |
| Dec 31, 2023 | 5,400 | 600 | 12.50% |
| Dec 31, 2022 | 4,800 | 900 | 23.08% |
| Dec 31, 2021 | 3,900 | 500 | 14.71% |
| Dec 31, 2020 | 3,400 | 400 | 13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Vertex Pharmaceuticals News
- 4 days ago - Best Defensive Stocks To Balance Tech Sector Volatility - Seeking Alpha
- 5 days ago - Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Nasdaq
- 6 days ago - SCHX, TJX, LOW, VRTX: Large Inflows Detected at ETF - Nasdaq
- 6 days ago - Harbor Capital Appreciation Fund Q3 2025 Portfolio Review - Seeking Alpha
- 7 days ago - 12 Days of Investing: My Top 12 Stocks to Buy Before 2026 - The Motley Fool
- 7 days ago - What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc? - Benzinga
- 10 days ago - 2 Healthcare Stocks to Buy Ahead of the New Year - The Motley Fool
- 10 days ago - Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Nasdaq